Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

VSIQQ brolucizumab (rbe) 120 mg/mL solution for injection in vial (349910)

ARTG ID

349910

ARTG Name

VSIQQ brolucizumab (rbe) 120 mg/mL solution for injection in vial

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

January 28, 2021

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Novartis Pharmaceuticals Australia Pty Ltd

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

Active Ingredients

Ingredient Name

brolucizumab

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

VSIQQ brolucizumab (rbe) 120 mg/mL solution for injection in vial (349910) - TGA 批准文号 | MedPath